Quest AD–Detect™ beta–amyloid 42/40 ratio test

Description

This proprietary laboratory analysis evaluates the plasma levels of beta amyloid 40 and 42 using liquid chromatography with tandem mass spectrometry. The resulting 42/40 ratio serves as a biomarker for assessing the risk of Alzheimer's disease.

Top Modifiers

Graph View

List View

HCPCS/CPT 90Reference laboratory services performed by an outside laboratory(82.76%)

HCPCS/CPT GYItem or service excluded from Medicare benefits(3.45%)

HCPCS/CPT AYNon-ESRD related item or service for ESRD patients(3.45%)

HCPCS/CPT GWService unrelated to hospice patient's terminal condition(3.45%)

Code Crosswalks

No crosswalks found.

Alternate Codes

No alternates found.

Billed With Codes

No codes found here.

Sources

We make no claims to ownership of the coding systems referenced on this platform. Codes and descriptions are produced from claims and chargemaster data available through the CMS-9915-F Transparency in Coverage Final Rule and via state or federal datasets. This service is provided solely as a reference to encourage use of these codes in our chargemaster review and automated billing tools, so that healthcare professionals can understand and correctly report these codes in their claims.

Federal and State Datasets

List of CPT/HCPCS Codes, Centers for Medicare & Medicaid Services (CMS)
I/OCE Quarterly Release Files, Centers for Medicare & Medicaid Services (CMS)
Physician Fee Schedule Relative Value Files, Centers for Medicare & Medicaid Services (CMS)
OPPS Addendum B, Centers for Medicare & Medicaid Services (CMS)
ASC Payment Addenda, Centers for Medicare & Medicaid Services (CMS)